PACS Group (NASDAQ: PACS) CAO sells 15,000 shares under 10b5-1 plan
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
PACS Group, Inc. Chief Accounting Officer Michelle Renee Lewis reported selling a total of 15,000 shares of common stock in three open-market transactions at weighted average prices around $45 per share. These sales were made pursuant to a Rule 10b5-1 trading plan adopted on March 3, 2026, and she continues to hold 355,338 shares directly after the transactions.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
Net Seller: 15,000 shares ($675,424)
Net Sell
3 txns
Insider
Lewis Michelle Renee
Role
Chief Accounting Officer
Sold
15,000 shs ($675K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 4,137 | $45.0406 | $186K |
| Sale | Common Stock | 6,663 | $45.0296 | $300K |
| Sale | Common Stock | 4,200 | $45.0141 | $189K |
Holdings After Transaction:
Common Stock — 355,338 shares (Direct, null)
Footnotes (1)
- The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 3, 2026. The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $45.00 to $45.06 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $45.00 to $45.115 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $45.00 to $45.15 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Key Figures
Total shares sold: 15,000 shares
Shares sold on July 1, 2026: 4,200 shares
Shares sold on July 2, 2026: 6,663 shares
+5 more
8 metrics
Total shares sold
15,000 shares
Aggregate open-market sales reported in Form 4
Shares sold on July 1, 2026
4,200 shares
Open-market sale of common stock
Shares sold on July 2, 2026
6,663 shares
Open-market sale of common stock
Shares sold on July 6, 2026
4,137 shares
Open-market sale of common stock
Weighted average price July 1
$45.0141 per share
Common stock sale weighted average price
Weighted average price July 2
$45.0296 per share
Common stock sale weighted average price
Weighted average price July 6
$45.0406 per share
Common stock sale weighted average price
Shares held after transactions
355,338 shares
Direct ownership following reported sales
Key Terms
Rule 10b5-1 trading plan, weighted average price, open-market sale, common stock
4 terms
Rule 10b5-1 trading plan regulatory
"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 3, 2026."
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
weighted average price financial
"The price reported in Column 4 is a weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
open-market sale financial
"transaction_action: open-market sale"
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
common stock financial
"The securities were sold in multiple transactions at prices ranging from $45.00 to $45.06 per share of common stock."
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
FAQ
What insider transactions did PACS (PACS) report in this Form 4?
PACS Group reported that Chief Accounting Officer Michelle Renee Lewis sold 15,000 shares of common stock in three open-market transactions at weighted average prices near $45 per share, leaving her with 355,338 shares directly held after the reported sales.
Who is the PACS Group insider involved in the latest Form 4 filing?
The insider is Michelle Renee Lewis, Chief Accounting Officer of PACS Group, Inc. She reported three open-market sales of common stock totaling 15,000 shares and now directly holds 355,338 shares following the transactions disclosed in the Form 4.
Were the PACS (PACS) insider sales made under a Rule 10b5-1 plan?
Yes. A footnote explains the reported sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 3, 2026, indicating the trades were pre-arranged under that plan.